Atrial fibrillation (Afib or AF) is a concern for patients using ibrutinib, as some 10% of WMers on ibrutinib may eventually develop it.
The IWMF is pleased to announce that Andrew Warden of WMozzies was presented with the 2019 Judith May Volunteer Award at the IWMF Educational Form in Philadelphia, PA.
This is your chance to share the Ed Forum excitement and view Dr. Steven Treon’s presentation LIVE and online from Philadelphia on Saturday, June 8, from 2:20-3:30 pm EDT.
Not once, but twice – IWMF has received the highest recognition from the largest most respected evaluator of charities.
Don’t forget to participate in the 3rd Walk for Waldenstrom’s on Sunday, June 9, 2019! You can walk with us, fundraise for us, or donate on a fellow WMer’s behalf.
An international team of researchers developed a risk-based stratification model to identify markers to predict the median time to progression for asymptomatic WM patients.
Now available online and via phone! CancerCare Webcast by Dr. Jorge Castillo (Dana-Farber Cancer Institute) and Dr. Stephen Ansell (Mayo Clinic).
All WMers share a similar diagnosis, yet each has a unique journey and fight for survival. Through my journey, I am now a stronger me than I would have been otherwise.
On Wednesday, April 10, from 12:30PM to 1:30PM US Eastern Time, Drs. Stephen Ansell and Jorge Castillo will share an update on treatment for WM. Register now – it’s free!
WM patients in the US may be eligible to receive financial assistance from the Patient Access Network (PAN) Foundation to help with deductibles, copays, and coinsurance.